Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001641172-25-016987

Options or other derivatives

  • Director acquired 40,565 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
PACE GARY W Director 2025-06-26 Grant or award · Stock Options +40,565 187,539 D
Loading xslF345X05/ownership.xml…